- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
The N3Connect Bulletin aims to inform, connect, and engage members of the N3C community. The bulletin includes updates on community events, news, important announcements, and opportunities for involvement, as well as stories and profiles about N3C community members and their achievements. To join the N3Connect Bulletin mailing list, please visit https://bit.ly/JoinN3Connect
The White House Office of Science and Technology Policy (OSTP) released comprehensive new recommendations to promote user data privacy for both public and private sector entities, focusing on mitigating bias and maximizing efficiency in an equitable way. The “National Strategy to Advance Privacy-Preserving Data Sharing and Analytics1” establishes clear objectives to aid the research, development
The N3Connect Bulletin aims to inform, connect, and engage members of the N3C community. The bulletin includes updates on community events, news, important announcements, and opportunities for involvement, as well as stories and profiles about N3C community members and their achievements. To join the N3Connect Bulletin mailing list, please visit https://bit.ly/JoinN3Connect
Artificial Intelligence and other Data Science approaches have shown the potential to transform healthcare in recent years. Novel algorithms can now improve the interpretation of images, expedite diagnoses, suggest medications, and predict the development of diseases or complications. Availability of cancer-related diverse data sets including EHR, Genomics, PROs, Claims, Wearable, Imaging via the
Over the past year, N3C's Data Ingestion & Harmonization Team has developed two scorecards that will be sent to all 77 released sites on a biweekly basis. The site-specific scorecard will return data quality metrics and feedback for the individual site while the site comparison scorecard will return data quality metrics and feedback of that site compared to the rest of the sites in either the OMOP
A National CTSA Coordinating Center that established a foundation to provide access to medical record data, innovative tools, and a diverse group of researchers are foundational to achieve equity through the science of translation! The CTSA Community has created a number of innovative resources to facilitate national coordination of translational research and enable health equity, diversity and
Dr. Melissa Haendel and Dr. Jakob Seidlitz will present "2022 DataWorks! Grand Prize Winners: Innovations in Data Sharing and Reuse" at the monthly Data Sharing and Reuse Seminar on March 10, 2023 at 12 p.m. EDT.
The N3Community Forum is a place to learn about new COVID-related studies, papers, and opportunities. This event is held on a weekly basis and features one to two presentations from members of the N3C community on selected topics regarding their work with N3C. Each presentation is followed by a discussion session open to participants. Monday, October 31, 2022 at 2pm-3pm PT / 5pm-6pm ET 1st Topic
SDoH are the non-clinical covariates of how people live, grow, learn and age and relates to how people manage stressors or prevent worsening health outcomes. Progressively, data about patient-level SDoH are collected using clinical screening tools for social needs and social risk factors. CD2H has led multiple SDoH synergistic initiatives relating to overall improvement of SDoH encoding and
Background and Aims In patients with chronic liver diseases (CLD) with or without cirrhosis, existing data on the risk of adverse outcomes with SARS-CoV-2 infection have been mixed or have limited generalizability.
PURPOSE
The attached files are provided to the CTSA Program Communications team for use in promoting and communication about the N3C.
The attached doc is guidance for how our hub partners should communicate about N3C efforts
Read the latest N3C preprint now published in medRxiv by authors: Joy Alamgir, Masanao Yajima, Rosa Ergas, Xinci Chen, Nicholas Hill, Naved Munir, Mohsan Saeed, Kenneth Gersing, Melissa Haendel, Christopher Chute, Ruhul Abid. Background: Drug repositioning is a key component of COVID-19 pandemic response, through identification of existing drugs that can effectively disrupt COVID-19 disease
NCATS has provided the FDA with access to the N3C Data Enclave. FDA investigators interested in accessing N3C COVID-19 data must complete appropriate human subjects and NIH security training, review and abide by NCATS technology transfer requirements, and submit a Data Use Request (DUR) detailing their proposed project and use of N3C data. For details on how FDA investigators can access the N3C